PGIM India Healthcare Fund Regular IDCW-Reinvestment | PGIM India Healthcare Fund NAV Today [10.87], Performance & History

Equity Sectoral Thematic Regular

Regular

Direct

1 Year Absolute Returns

12.76% ↑

NAV (₹) on 21 May 2026

10.87

1 Day NAV Change

-0.09%

Risk Level

Very High Risk

Rating

PGIM India Healthcare Fund is a Equity mutual fund categorized under Sector, offered by PGIM India Asset Management Pvt. Ltd.. Launched on 19 Nov 2024, investors can start with a minimum SIP of ₹100 ... Read more

NAV History

Fund Details

Min. SIP Amount

₹1,000

Inception Date

19 Nov 2024

Min. Lumpsum Amount

₹ 5,000

Fund Age

1 Yrs

AUM

₹ 92.44 Cr.

Benchmark

BSE Healthcare Total Return

Expense Ratio

2.47%

Scheme Type

Open Ended

Exit Load

0.50%

Asset Allocation

AUM

₹ 92.44 Cr

Equity

387.95%

Money Market & Cash

12.29%

Other Assets & Liabilities

0.54%

Sector Holdings

Sectors	Weightage
Pharmaceuticals	65.05%
Hospitals & Medical Services	25.13%
Chemicals - Others	3.06%
Treps/Reverse Repo	2.93%
Financial Technologies (Fintech)	1.38%
Finance - Non Life Insurance	1.17%
Lenses/Optical Care	0.75%
IT Enabled Services	0.55%

See All

Stock Holdings

Name	Weightage	Value (in Cr.)	Sector
Sun Pharmaceutical Industries Ltd.	11.77%	₹ 10.88	Pharmaceuticals
Divi's Laboratories Ltd.	10.09%	₹ 9.32	Pharmaceuticals
Aster DM Healthcare Ltd.	6.40%	₹ 5.92	Hospitals & Medical Services
JB Chemicals & Pharmaceuticals Ltd.	6.36%	₹ 5.88	Pharmaceuticals
Rubicon Research Ltd.	5.95%	₹ 5.50	Pharmaceuticals
Max Healthcare Institute Ltd.	5.29%	₹ 4.89	Hospitals & Medical Services
Mankind Pharma Ltd.	5.12%	₹ 4.73	Pharmaceuticals
Ajanta Pharma Ltd.	4.66%	₹ 4.31	Pharmaceuticals
Krishna Inst of Medical Sciences Ltd.	3.77%	₹ 3.48	Hospitals & Medical Services
Navin Fluorine International Ltd.	3.06%	₹ 2.83	Chemicals - Others
Clearing Corporation of India Ltd.	2.93%	₹ 2.71	Others
Neuland Laboratories Ltd.	2.88%	₹ 2.66	Pharmaceuticals
Dr. Lal Path Labs Ltd.	2.87%	₹ 2.66	Hospitals & Medical Services
Dr. Reddy's Laboratories Ltd.	2.87%	₹ 2.65	Pharmaceuticals
Abbott India Ltd.	2.86%	₹ 2.64	Pharmaceuticals
Torrent Pharmaceuticals Ltd.	2.61%	₹ 2.41	Pharmaceuticals
Sai Life Sciences Ltd	2.52%	₹ 2.33	Pharmaceuticals
Anthem Biosciences Ltd.	2.26%	₹ 2.09	Pharmaceuticals
Jupiter Life Line Hospitals Ltd.	1.99%	₹ 1.84	Hospitals & Medical Services
Global Health Ltd.	1.76%	₹ 1.63	Hospitals & Medical Services
Cipla Ltd.	1.58%	₹ 1.46	Pharmaceuticals
Fortis Healthcare Ltd.	1.51%	₹ 1.40	Hospitals & Medical Services
Lupin Ltd.	1.42%	₹ 1.31	Pharmaceuticals
Pfizer Ltd.	1.40%	₹ 1.29	Pharmaceuticals
PB Fintech Ltd.	1.38%	₹ 1.28	Financial Technologies (Fintech)
ICICI Lombard General Insurance Co. Ltd.	1.17%	₹ 1.08	Finance - Non Life Insurance
Dr Agarwal's Health Care Ltd.	1.01%	₹ 0.93	Hospitals & Medical Services
Lenskart Solutions Ltd.	0.75%	₹ 0.70	Lenses/Optical Care
Orchid Pharma Ltd.	0.70%	₹ 0.64	Pharmaceuticals
Sagility Ltd.	0.55%	₹ 0.51	IT Enabled Services
Dr Agarwal's Eye Hospital Ltd.	0.53%	₹ 0.49	Hospitals & Medical Services

See All

Returns

	Annualised returns
	9M	1Y	2Y	3Y
Fund returns	8.27%	12.76%	-	-
Category returns	0.82%	4.33%	8.62%	23.42%

Fund Objective

The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. ... Read more

AMC Details

Name

PGIM India Asset Management Pvt. Ltd.

Date of Incorporation

13 May 2010

CEO

Mr. Abhishek Tiwari

CIO

Mr. Vinay Paharia

Type

Foreign

Address

Nirlon House, 2nd Floor, Dr. Annie Besant Road, Worli, Mumbai, Maharashtra, India - 400030

Website

http://www.dhflpramericamf.com

[email protected]

Top Funds from Equity - Sectoral/Thematic

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
SBI Technology Opportunities Fund Sector Regular	₹112.28	-11.28%	32.98%	65.33%	₹4,240	1.89%	Very High
SBI Technology Opportunities Fund Sector Regular	₹112.28	-11.28%	32.98%	65.33%	₹4,240	1.89%	Very High
SBI Technology Opportunities Fund Sector Regular	₹186.46	-11.28%	32.98%	65.32%	₹4,240	1.89%	Very High
Baroda BNP Paribas Business Cycle Fund - Direct Plan Diversified Direct	₹13.91	-5.60%	32.72%	0.00%	₹561	0.98%	Very High
Baroda BNP Paribas Business Cycle Fund - Direct Plan Diversified Direct	₹13.91	-5.60%	32.72%	0.00%	₹561	0.98%	Very High
Axis Innovation Fund - Direct Plan Diversified Direct	₹16.86	-2.49%	32.65%	55.97%	₹1,177	1.18%	Very High
Axis Innovation Fund - Direct Plan Sector Direct	₹16.86	-2.49%	32.65%	55.97%	₹1,177	1.18%	Very High
ICICI Prudential Technology Fund - Direct Plan Sector Direct	₹189.90	-12.77%	32.19%	56.52%	₹13,068	1.41%	Very High
Taurus Banking And Financial Services Fund - Direct Plan Sector Direct	₹57.21	-2.60%	32.16%	65.87%	₹11	1.68%	Very High
Taurus Banking And Financial Services Fund - Direct Plan Sector Direct	₹57.88	-2.61%	32.15%	65.89%	₹11	1.68%	Very High

Top Funds from PGIM India Asset Management Pvt. Ltd.

Scheme Name	NAV	Returns 1Y 3Y 5Y			AUM (Cr)	Expense Ratio	Risk Meter
PGIM India Large Cap Fund - Direct Plan Diversified Direct	₹385.12	-2.66%	32.58%	55.28%	₹544	0.89%	Very High
PGIM India Dynamic Bond Fund - Direct Plan Income Direct	₹1,564.48	4.91%	30.99%	51.49%	₹83	0.51%	Moderate
PGIM India Dynamic Bond Fund - Direct Plan Income Direct	₹1,564.48	4.91%	30.99%	51.49%	₹83	0.51%	Moderate
PGIM India ELSS Tax Saver Fund ELSS Regular	₹32.61	-4.98%	29.15%	62.40%	₹700	2.40%	Very High
PGIM India Balanced Advantage Fund - Direct Plan Hybrid Direct	₹16.11	-0.80%	29.09%	52.99%	₹830	0.70%	Very High
PGIM India Aggressive Hybrid Equity Fund Hybrid Regular	₹125.76	-1.92%	28.98%	44.29%	₹204	2.38%	Very High
PGIM India Aggressive Hybrid Equity Fund - Direct Plan Hybrid Direct	₹21.55	22.93%	28.96%	0.00%	₹204	0.80%	Very High
PGIM India Aggressive Hybrid Equity Fund - Direct Plan Hybrid Direct	₹21.55	22.93%	28.96%	0.00%	₹204	0.80%	Very High
PGIM India Global Equity Opportunities Fund of Fund -... International/ Global Direct	₹29.18	-19.10%	27.15%	76.63%	₹1,694	1.38%	Very High
PGIM India Small Cap Fund Diversified Regular	₹13.46	-0.52%	27.10%	0.00%	₹1,539	2.61%	Very High

FAQs

What is the current NAV of PGIM India Healthcare Fund Regular IDCW-Reinvestment?

The current Net Asset Value (NAV) of PGIM India Healthcare Fund Regular IDCW-Reinvestment is ₹10.87 as of 21 May 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.

What is the fund size (AUM) of PGIM India Healthcare Fund Regular IDCW-Reinvestment?

The Assets Under Management (AUM) of PGIM India Healthcare Fund Regular IDCW-Reinvestment is ₹92.44 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.

What are the historical returns of PGIM India Healthcare Fund Regular IDCW-Reinvestment?

PGIM India Healthcare Fund Regular IDCW-Reinvestment has delivered returns of 12.76% (1 Year), 0.00% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.

What is the risk level of PGIM India Healthcare Fund Regular IDCW-Reinvestment?

PGIM India Healthcare Fund Regular IDCW-Reinvestment has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.

What is the minimum investment amount for PGIM India Healthcare Fund Regular IDCW-Reinvestment?

The minimum lumpsum investment required for PGIM India Healthcare Fund Regular IDCW-Reinvestment is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹1,000, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article